SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-011180
Filing Date
2017-12-01
Accepted
2017-12-01 17:26:42
Documents
21

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1629692
2 filename2.htm EX-3 101196
3 filename3.htm EX-4 179008
4 filename4.htm EX-10 183670
5 filename5.htm EX-10 641170
6 filename6.htm EX-10 30320
7 filename7.htm EX-10 59232
8 filename8.htm EX-10 59307
9 filename9.htm EX-10 23692
10 GRAPHIC g475892g07q36.jpg GRAPHIC 58587
11 GRAPHIC g475892g14y95.jpg GRAPHIC 68176
12 GRAPHIC g475892g16k55.jpg GRAPHIC 77969
13 GRAPHIC g475892g16r29.jpg GRAPHIC 119380
14 GRAPHIC g475892g16s95.jpg GRAPHIC 115059
15 GRAPHIC g475892g21d19.jpg GRAPHIC 99976
16 GRAPHIC g475892g74c97.jpg GRAPHIC 60787
17 GRAPHIC g475892g77j27.jpg GRAPHIC 60355
18 GRAPHIC g475892g79t13.jpg GRAPHIC 76946
19 GRAPHIC g475892g80i74.jpg GRAPHIC 62158
20 GRAPHIC g475892g80m33.jpg GRAPHIC 43816
21 GRAPHIC g475892g99k81.jpg GRAPHIC 80747
  Complete submission text file 0000950123-17-011180.txt   4181701
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01761 | Film No.: 171234995
SIC: 2834 Pharmaceutical Preparations